1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Time to tumor progession (TTP) of patients with octreotide-positive metastatic low-grade well-differentiated gastrointestinal neuroendocrine tumors (GEPNETs)
    Meeting Abstract

    Do, K. G.; Wyluda, E.; Capanu, M.; Tang, L. H.; Reidy, D. L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Induction chemotherapy followed by chemoradiotherapy and TME for high-risk locally advanced rectal cancer
    Meeting Abstract

    Ding, P.; Weiser, M. R.; Hajj, C.; Saltz, L.; Segal, N. H.; Goodman, K. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Gemcitabine (gem) as salvage therapy in metastatic colorectal adenocarcinoma (mCRC)
    Meeting Abstract

    Cercek, A.; Gollub, M.; Saltz, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical/pathologic features and survival of patients with fibrolamellar-hepatocellular carcinoma (FLL-HCC): Data from the Fibrolamellar-Hepatocellular (FLL-HCC) Consortium
    Meeting Abstract

    Ang, C.; Venook, A. P.; Choti, M. A.; DeMatteo, R. P.; Kelley, R. K.; Cosgrove, D.; McGuire, J. P.; Torbenson, M. S.; Pawlik, T. M.; Jarnagin, W. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC)
    Meeting Abstract

    Abou-Alfa, G. K.; Gansukh, B.; Chou, J. F.; Shia, J.; Capanu, M.; Kalin, M.; Chen, H. X.; Zojwalla, N. J.; Katz, S.; Reidy, D. L.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical outcomes in patients age 40 or younger at diagnosis of synchonous metastatic colorectal cancer
    Meeting Abstract

    Lowery, M. A.; Gallagher, D. J.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical outcomes in pancreatic adenocarcinoma (PAC) associated with a known BRCA mutation
    Meeting Abstract

    Lowery, M. A.; Stadler, Z. K.; Ludwig, E.; Salo-Mullen, E.; D'Adamo, D. R.; Allen, P. J.; Kurtz, R. C.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)
    Meeting Abstract

    Smyth, E. C.; Janjigian, Y. Y.; Robinson, E.; Sheehy, E. C.; Karpenko, I.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Meeting Abstract

    Janjigian, Y. Y.; Villegas, N. T.; Holland, J. P.; Shah, M. A.; Divilov, V.; Kelsen, D. P.; Lewis, J. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma
    Meeting Abstract

    Ilson, D.; Janjigian, Y. Y.; Shah, M. A.; Tang, L. H.; Kelsen, D. P.; Campbell, J.; Fuqua, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save